Journal Article
Leisi, Remo; Ruprecht, Nico; Kempf, Christoph; Ros, Carlos
(2013).
Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropism.
Journal of virology, 87(24), pp. 13161-13167.
American Society for Microbiology
10.1128/JVI.02548-13
Wolfisberg, Raphael; Ruprecht, Nico; Kempf, Christoph; Ros, Carlos
(2013).
Impaired genome encapsidation restricts the in vitro propagation of human parvovirus B19.
Journal of virological methods, 193(1), pp. 215-225.
Elsevier
10.1016/j.jviromet.2013.06.003
Cai, Kang; Gröner, Albrecht; Dichtelmüller, Herbert O.; Fabbrizzi, Fabrizio; Flechsig, Eckhard; Gajardo, Rodrigo; von Hoegen, Ilka; Jorquera, Juan I.; Kempf, Christoph; Kreil, Thomas R.; Lee, Douglas C.; Moscardini, Mila; Pölsler, Gerhard; Roth, Nathan J.
(2013).
Prion removal capacity of plasma protein manufacturing processes.
Transfusion, 53(9), pp. 1894-1905.
Wiley-Blackwell
10.1111/trf.12050
Quattrocchi, Silva; Ruprecht, Nico; Bönsch, Claudia; Bieli, Sven; Zürcher, Christoph; Boller, Klaus; Kempf, Christoph; Ros, Carlos
(2012).
Characterization of the early steps of human parvovirus B19 infection.
Journal of virology, 86(17), pp. 9274-9284.
Baltimore: American Society for Microbiology
10.1128/JVI.01004-12
Dichtelmüller, Herbert O.; Biesert, Lothar; Fabbrizzi, Fabrizio; Falbo, Anna; Flechsig, Eckhard; Gröner, Albrecht; von Hoegen, Ilka; Kempf, Christoph; Kreil, Thomas R.; Lee, Douglas C.; Pölsler, Gerhard; Roth, Nathan J.
(2011).
Contribution to safety of immunoglobulin and albumin from virus partitioning and inactivation by cold ethanol fractionation: a data collection from Plasma Protein Therapeutics Association member companies.
Transfusion, 51(7), pp. 1412-1430.
Malden, Mass.: Wiley-Blackwell
10.1111/j.1537-2995.2010.03003.x
Bönsch, Claudia; Zuercher, Christoph; Lieby, Patricia; Kempf, Christoph; Ros, Carlos
(2010).
The globoside receptor triggers structural changes in the B19V capsid that facilitate virus internalization.
Journal of virology, 84(22), pp. 11737-11746.
Baltimore: American Society for Microbiology
10.1128/JVI.01143-10
Bönsch, Claudia; Kempf, Christoph; Müller, Ivo; Manning, Laurens; Laman, Moses; Davis, Timothy M.E.; Ros, Carlos
(2010).
Chloroquine and its derivatives exacerbate B19V-associated anemia by promoting viral replication.
PLoS neglected tropical diseases, 4(4), e669.
San Francisco, Calif.: Public Library of Science
10.1371/journal.pntd.0000669
Dichtelmüller, Herbert O.; Biesert, Lothar; Fabbrizzi, Fabrizzio; Gajardo, Rodriguez; Gröner, Albrecht; von Hoegen, Ilka; Jorquera, Juan I.; Kempf, Christoph; Kreil, Thomas R.; Pifat, Dominique; Osheroff, Wendy; Poelsler, Gerhard
(2009).
Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Protein Therapeutics Association member companies.
Transfusion, 49(9), pp. 1931-1943.
Malden, Mass.: Wiley-Blackwell
10.1111/j.1537-2995.2009.02222.x
Boensch, Claudia; Kempf, Christoph; Ros, Carlos
(2008).
Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity.
Journal of virology, 82(23), pp. 11784-11791.
Baltimore: American Society for Microbiology
10.1128/JVI.01399-08
Stucki, Martin; Boschetti, Nicola; Schäfer, Wolfram; Hostettler, Thomas; Käsermann, Fabian; Nowak, Thomas; Gröner, Albrecht; Kempf, Christoph
(2008).
Investigations of prion and virus safety of a new liquid IVIG product.
Biologicals, 36(4), pp. 239-247.
London: Elsevier
10.1016/j.biologicals.2008.01.004
Mani, Bernhard; Gerber, Marco; Lieby, Patricia; Boschetti, Nicola; Kempf, Christoph; Ros, Carlos
(2007).
Molecular mechanism underlying B19 virus inactivation and comparison to other parvoviruses.
Transfusion, 47(10), pp. 1765-1774.
Malden, Mass.: Wiley-Blackwell
10.1111/j.1537-2995.2007.01393.x
Kempf, Christoph; Stucki, Martin; Boschetti, Nicola
(2007).
Pathogen inactivation and removal procedures used in the production of intravenous immunoglobulins.
Biologicals, 35(1), pp. 35-42.
London: Elsevier
10.1016/j.biologicals.2006.01.002
Ros, Carlos; Baltzer, Claudia; Mani, Bernhard; Kempf, Christoph
(2006).
Parvovirus uncoating in vitro reveals a mechanism of DNA release without capsid disassembly and striking differences in encapsidated DNA stability.
Virology, 345(1), pp. 137-147.
New York, N.Y.: Academic Press
10.1016/j.virol.2005.09.030
Mani, Bernhard; Baltzer, Claudia; Valle, Noelia; Almendral, José; Kempf, Christoph; Ros, Carlos
(2006).
Low pH-dependent endosomal processing of the incoming parvovirus minute virus of mice virion leads to externalization of the VP1 N-terminal sequence (N-VP1), N-VP2 cleavage, and uncoating of the full-length genome.
Journal of virology, 80(2), pp. 1015-1024.
Baltimore: American Society for Microbiology
10.1128/JVI.80.2.1015-1024.2006
Bauman, P; Lawrence, LA; Biesert, L; Dichtelmüller, H; Fabbrizzi, F; Gajardo, R; Gröner, A; Jorquera, JI; Kempf, Christoph; Kreil, TR; von Hoegen, I; Pifat, DY; Petteway, SR Jr; Cai, K
(2006).
Critical factors influencing prion inactivation by sodium hydroxide.
Vox sanguinis, 91(1), pp. 34-40.
Oxford: Wiley-Blackwell
10.1111/j.1423-0410.2006.00790.x
Käsermann, Fabian; Kempf, Christoph
(2006).
Virus membrane proteins and proteinaceous pores.
Future virology, 1(6), pp. 823-831.
London: Future Medicine Ltd.
10.2217/17460794.1.6.823
Ros, Carlos; Gerber, Marco; Kempf, Christoph
(2006).
Conformational changes in the VP1-unique region of native human parvovirus B19 lead to exposure of internal sequences that play a role in virus neutralization and infectivity.
Journal of virology, 80(24), pp. 12017-12024.
Baltimore: American Society for Microbiology
10.1128/JVI.01435-06
Book Section
Kempf, Christoph; Späth, Peter Julius
(2013).
Pathogen safety of Immunoglobulin Preparations.
In:
Clinical use of immunoglobulins (pp. 33-57).
Bremen: UNI-med
Zuercher, Adrian W.; Amsler, Lorenz; Amstutz, Hanspeter; Andresen, Irmgard; Bolli, Reinhard; Hummel, Wolfram; Käsermann, Fabian; Kempf, Christoph; Lerch, Peter; Lörtscher, Marius; Schaub, Alexander; Spycher, Martin; Miescher, Sylvia M.
(2011).
C2 Plasma-derived immunoglobulins.
In:
Nijkamp, Frans P.; Parnham, Michael J.
(eds.)
Principles of Immunopharmacology, Part 3 (pp. 271-301).
Heidelberg: Springer Verlag
10.1007/978-3-0346-0136-8_17
Borte, M; Horneff, G; Kempf, Christoph; Kaise, R; Korinthenberg, R; Körholz, D; Mauz-Körholz, C; Nadal, D; Niggemann, B; Roos, R; Späth, Peter; Wahn, V; Wehmeier, A; Zepp, F; Zielen, S
(2007).
Herstellung von intravenös verabreichbaren Immunglobulinen und Pathogensicherheit.
In:
Wahn, Volker
(ed.)
Klinischer Einsatz von Immunglobulinen (pp. 28-47).
Bremen et al.: UNI-MED
Conference or Workshop Item
Quattrocchi, S.; Ruprecht, N.; Bonsch, C.; Bieli, S.; Zurcher, C.; Boller, K.; Kempf, C.; Ros, C.
(2012).
Early steps of human parvovirus B19 infection.
In:
USGEB Annual Meeting 2012.
Quattrocchi, S.; Ruprecht, N.; Bonsch, C.; Bieli, S.; Zurcher, C.; Boller, K.; Kempf, C.; Ros, C.
(2012).
Characterization of the Early Steps of Human Parvovirus B19 Infection.
In:
XIV International Parvovirus Workshop.
Käsermann, Fabian; Jürs, Mathias; Kempf, Christoph
(2006).
Prionen Erkrankungen beim Menschen und die Sicherheit von Blut und plasmatischen Produkten.
In:
Seifried, Erhard
(ed.)
Quo vadis Plasmaproteine (pp. 20-33).
München: Gesellschaft für Thrombose- und Hämostaseforschung